Tuesday, October 18th, 2011
The second annual New Paradigms conference is taking place January 11-12, 2012 at the Marine's Memorial Club and Hotel in San Francisco. This event, produced by The Conference Forum, is designed to help emerging biotechs identify alternative sources of capital and provide insights from experienced executives on partnering strategies; and ...
Posted in Health | Comments Off
Saturday, September 24th, 2011
Janssen Biotech, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved REMICADE® (infliximab) for the treatment of moderately to severely active ulcerative colitis (UC) in pediatric patients who have had an inadequate response to conventional therapy. This marks the 16th approval of REMICADE® in the ...
Posted in Health | Comments Off
Tuesday, April 19th, 2011
Aduro BioTech, a clinical-stage immunotherapy company, has licensed GVAX Pancreas Cancer Vaccine (GVAX Pancreas) and GVAX Prostate Cancer Vaccine (GVAX Prostate) from BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) in exchange for milestone and royalty payments after commercialization. Aduro also has an option to additional GVAX cancer vaccine indications, all for use ...
Posted in Health | Comments Off
Monday, April 18th, 2011
Active Biotech AB (NASDAQ OMX NORDIC: ACTI) and Ipsen (Paris:IPN)(Euronext: IPN; ADR: IPSEY) announced today that they have entered into a broad partnership to co-develop and commercialize Active Biotech's investigational compound Tasquinimod "TASQ". A global Phase III trial of TASQ in men with metastatic castrate-resistant prostate cancer (CRPC) was recently ...
Posted in Health | Comments Off
Saturday, March 5th, 2011
Sinovac Biotech Ltd. (Nasdaq:SVA - News), a leading provider of biopharmaceutical products in China, announced it submitted the application to commence clinical trials for its 13-valent pneumococcal conjugate vaccine (PCV) to China's State Food and Drug Administration (SFDA) on March 3, 2011. Sinovac initiated its PCV research ...
Posted in Health | Comments Off
